🚨Out today @TheLancet from @TheCrick@UCLHResearch Legacy study
thelancet.com/journals/lance…
Two different COVID-19 mRNA vaccines were deployed for 5th dose boosters in the UK #JCVI
We tested if either 💉 generated neutralizing antibodies against BA.2.86 & JN.1
A short🧵
👇
Have you been invited?
Have you received an invitation to the PHOSP-COVID 5-year follow-up study?
🖥️ A short online survey 🧠 optional cognitive tests – your experience still matters.
Paper published today in @BMJ_Open from our group describing trajectory of 3590 patients with #longcovid Important insights into inpatient and outpatient treated cohorts, impact of vaccine before illness, recovery trajectories and health economics bmjopen.bmj.com/content/16/1…
Clinical trajectories of > 3500 patients with #LongCovid@uclh 2020-2024.
🚨 Only 1/3 recovered🚨
➡️ Vaccination predicts recovery
➡️ Severe fatigue, POTS and PEM predicts slower recovery/non-recovery
➡️ LC clinic *reduces* GP and ED visits
👇
bmjopen.bmj.com/content/16/1…
Lecturer in Immunology of Host-pathogen Dynamics at Queen Mary University of London. Great opportunity to work with Emma Wall, setting up a new lab at QMUL. jobs.ac.uk/job/DPT444/lectur…
Great to see this published. A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID doi.org/10.1038/s41467-025-6…
We're still recruiting! Do you have Long Covid & 18-80 years? The University of Leicester are running a trial to see if an anti-inflammatory drug helps people with LC feel better. If you are interested in taking part, please contact phosp-i@leicester.ac.uk @long_covid#LongCovid
"We often talk about the importance of research but rarely about the researchers. We celebrate innovation but overlook the innovators... blueprints do not build anything without skilled hands"
A great Keystone meeting on Long COVID this week in Santa Fe. The field has made great progress recently, but there is much more to do. Exciting science presented about viral and immune mechanisms, clinical data and future clinical trials. keystonesymposia.org/confere…
It has been five years since the post-Covid clinic was set up outside University College Hospital.
The team has since expanded and continues to provide vital support as new cases emerge and some patients experience long-term effects.
buff.ly/iCJkwnM
We can see our LINE symposium already on the horizon (9th of June) @TheCrick. shorturl.at/MyWNl 🥳
You can now submit your abstracts (talk or poster) until the EXTENDED DEADLINE on the 12th of May here: shorturl.at/7KuXL
Free registration shorturl.at/wLyWY
New in Nature Comms: We applied metagenomic and targeted NGS to serum samples from undiagnosed febrile patients across Uganda. This work highlights how NGS can transform viral surveillance in LMICs—especially with infrastructure now in place post-COVID. 🔗 nature.com/articles/s41467-0…
5 years on. Sobering to think 1in 280 people in UK have died of #COVID. The research journey has been steep but despite vaccines and antivirals the immune vulnerable remain at risk and we still have no treatments for #longcovid. So much more to do bbc.co.uk/news/articles/c798…
We are very proud to bring you a highly requested new type of event this year 🙌:
an ECR Careers Meeting 🤩
Join us Thurs. 13th March at the @iit_ucl Pears Building (Hampstead)
🚨Registration is FREE! Link to register NOW! immunology.org/events/bsi-l...
For more details👇
Europe needs a sustainably funded influenza research and response network - especially in the light of H5N1 and current developments in the US. Read our commentary in The Lancet ID:
thelancet.com/journals/lanin…
With @wendybarclay11, @MarionKoopmans and many other colleagues.